Delaware Crossing Investor Group

Vytala is a food technology company specializing in enhancing nutrition through innovative solutions. It operates a clinical nutrition business, offering structured lipid technology that improves nutrient absorption, particularly for those with fat malabsorption issues. This technology helps clients avoid nutrient deficiencies, gastrointestinal diseases, and chronic malnutrition, supporting overall health and well-being.

Measure Studio develops a platform for creating data-driven social media content strategies. It consolidates and analyzes social media data from multiple platforms, enabling digital publishers, brands, agencies, and influencers to improve their content. The platform offers a secure environment for managing analytics.

Founded in 1998, SunRay Scientific specializes in manufacturing advanced materials, primarily conductive adhesives. These products enable high throughput processes in flexible electronics assembly, catering to industries such as healthcare, military defense, and energy.

Vesteck is a clinical-stage medical device company specializing in innovative solutions for aortic repair, structural heart, and gastrointestinal markets. Its flagship product, the Suture-Tight™ nitinol suture delivery catheter, aims to address significant global challenges in endovascular aortic repair by providing a novel technology for physicians and patients.

Ophidion is a biotechnology company focused on developing therapeutics for central nervous system disorders, particularly neurodegenerative diseases such as Alzheimer's, Parkinson's, and Huntington's disease. Utilizing a Trojan horse strategy, the company exploits an endogenous receptor-mediated transport system to deliver small molecule drugs and biologics directly into the brain. Ophidion specializes in gene-silencing therapies, including oligonucleotides and small interfering ribonucleic acids (siRNAs), which can be administered intravenously. In addition to its core focus on neurodegenerative diseases, Ophidion is advancing an innovative program aimed at treating anxiety-related disorders, which includes a patented companion biomarker diagnostic to optimize patient selection for treatment. The company's platform technology is versatile, capable of delivering various classes of drugs, including macromolecules like gene therapeutics, antibodies, and peptides, positioning Ophidion at the forefront of therapeutic advancements in CNS treatment.

ThruPore Technologies designs and manufactures porous carbon support structures for industrial catalysts, producing heterogeneous catalysts in pellet and powder forms. It focuses on palladium on carbon driven reactions, seeking improved porosity and dispersion within the catalyst support. The company develops high-porosity carbon materials for applications across precious metal and carbon-only catalysts, as well as fuel cell and battery materials, delivering refined end products for industrial clients. The company was founded in 2012 and is headquartered in Bear, Delaware.

Tobly is a developer of a cloud-based online rental platform specializing in construction equipment rental services. The company provides a range of major equipment, including cranes, scissor lifts, and excavators. Tobly's platform allows clients to efficiently manage the entire lifecycle of the rental process, streamlining operations for construction projects.

OnlySky is a cloud-based software platform that offers a customizable, white-label solution for ski areas, allowing guests to create their ideal skiing experience directly on the resort's website. The platform integrates various functionalities, enabling ski area staff to manage inventory, eCommerce, point of sale systems, ski school operations, and events from a single interface. By eliminating upfront fees and ensuring user-friendliness, OnlySky has become a preferred choice for independent ski areas across North America and snow schools globally. The technology enhances guest engagement, facilitating processes such as equipment rental and instructor booking through users' smartphones, ultimately improving the overall guest experience at ski resorts.

Life.io is the world’s first web-based platform specifically designed to help people make better decisions every moment, to take care of themselves more, to engage more, to simply live more. Delivered through insurance companies or employers, it’s always on, sharing inspired ideas on how to live better today and every day after.

Annovis Bio is a clinical-stage pharmaceutical company focused on developing drugs to treat neurodegenerative disorders. Its lead compound, ANVS401, is in Phase 2a trials for Alzheimer's and Parkinson's diseases. The company also develops ANVS405 for neuroprotection post-traumatic brain injury/stroke, and ANVS301 for cognitive enhancement in late-stage AD.

Founded in 2010, Hulafrog operates a network of local websites that connect parents with kid-focused events, businesses, and each other. It enables local businesses to promote their services and allows parents to discover activities, classes, and family-friendly locations via web, mobile, and email. Hulafrog offers advertising packages for local, regional, and national businesses.

Novira Therapeutics is a clinical‑stage biopharmaceutical company that discovers and develops oral antiviral drugs targeting the capsid of hepatitis B virus and human immunodeficiency virus. Its pipeline focuses on first‑in‑class capsid inhibitors that can be used alone or with existing therapies, aiming to overcome limitations of current polymerase inhibitors and drug‑resistant HIV strains. The company was founded in 2006 as Molecmo Nanobiotechnologies and is headquartered in Doylestown, Pennsylvania. It has pursued partnerships and collaborations to advance its candidates toward clinical evaluation.

Novira Therapeutics is a clinical‑stage biopharmaceutical company that discovers and develops oral antiviral drugs targeting the capsid of hepatitis B virus and human immunodeficiency virus. Its pipeline focuses on first‑in‑class capsid inhibitors that can be used alone or with existing therapies, aiming to overcome limitations of current polymerase inhibitors and drug‑resistant HIV strains. The company was founded in 2006 as Molecmo Nanobiotechnologies and is headquartered in Doylestown, Pennsylvania. It has pursued partnerships and collaborations to advance its candidates toward clinical evaluation.

Compliance Assurance Corporation specializes in on-demand governance, risk, and compliance solutions tailored for the insurance industry. Founded in 2003 and based in Pittsburgh, Pennsylvania, the company offers a range of products designed to streamline compliance processes and reduce associated costs. Among its key offerings is the Compliance Assured Enterprise, which provides comprehensive compliance packages for insurance carriers and their extended enterprises. Additionally, the Compliance Assured Producer Network equips Compliance Officers with essential tools to manage and mitigate risks linked to extended enterprise compliance. Through its innovative solutions, Compliance Assurance Corporation aims to enhance visibility and efficiency in governance, risk management, and compliance for its clients in the insurance sector.

NanoPack, Inc. is a materials science company founded in 2004 and located in Wayne, Pennsylvania. The company specializes in the development and marketing of barrier materials primarily for the food packaging industry. NanoPack's product offerings include polyethylene terephthalate, polylactic acid, and oriented polypropylene barrier coated films, along with liquid coatings used to create packaging films. These innovative materials are designed to enhance the preservation of various food products, including snack foods, dried fruits, coffee, cereals, and baked goods, while also being cost-effective and environmentally friendly.